| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 4,403,400 | 3,938,900 | 3,063,300 | | Cost of Revenue | 761,200 | 673,200 | 575,700 | | | Gross Profit | 3,642,200 | 3,265,700 | 2,487,600 | | | Operating Expenses | | Research Development | 797,900 | 718,100 | 1,055,500 | | Selling General and Administrative | 1,856,000 | 1,680,100 | 1,333,400 | | Non Recurring | 41,300 | 26,800 | 22,300 | | Others | 150,900 | 121,300 | 79,600 | | | | Total Operating Expenses | 2,846,100 | 2,546,300 | 2,490,800 | | | | Operating Income or Loss | 796,100 | 719,400 | (3,200) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 51,700 | 39,700 | 43,900 | | Earnings Before Interest And Taxes | 847,800 | 759,100 | 40,700 | | Interest Expense | 60,600 | 71,400 | 60,200 | | Income Before Tax | 787,200 | 687,700 | (19,500) | | Income Tax Expense | 207,000 | 186,200 | 107,500 | | Minority Interest | (1,600) | (500) | (400) | | | | Net Income From Continuing Ops | 578,600 | 501,000 | (127,400) | | | Non-recurring Events | | Discontinued Operations |
-
| (1,700) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 578,600 | 499,300 | (127,400) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $578,600 | $499,300 | ($127,400) |
|
1.48% Nasdaq 
Income Statement
